Hopes, Promises, and Future Directions of Gene and Cell Therapies in France

Hum Gene Ther. 2016 Feb;27(2):96-7. doi: 10.1089/hum.2016.29020.nca.
No abstract available

Publication types

  • Review

MeSH terms

  • Adrenoleukodystrophy / genetics
  • Adrenoleukodystrophy / pathology
  • Adrenoleukodystrophy / therapy
  • Cell- and Tissue-Based Therapy / methods
  • Cell- and Tissue-Based Therapy / trends*
  • Clinical Trials as Topic
  • France
  • Genetic Therapy / methods
  • Genetic Therapy / trends*
  • Genetic Vectors / chemistry*
  • Genetic Vectors / metabolism
  • Heart Failure / genetics
  • Heart Failure / pathology
  • Heart Failure / therapy
  • Hemoglobinopathies / genetics
  • Hemoglobinopathies / pathology
  • Hemoglobinopathies / therapy
  • Human Embryonic Stem Cells / cytology
  • Human Embryonic Stem Cells / physiology
  • Human Embryonic Stem Cells / transplantation*
  • Humans
  • Mucopolysaccharidosis III / genetics
  • Mucopolysaccharidosis III / pathology
  • Mucopolysaccharidosis III / therapy
  • Oncolytic Virotherapy / methods*
  • Oncolytic Virotherapy / trends
  • Pancreatic Neoplasms / genetics
  • Pancreatic Neoplasms / pathology
  • Pancreatic Neoplasms / therapy
  • Retinitis Pigmentosa / genetics
  • Retinitis Pigmentosa / pathology
  • Retinitis Pigmentosa / therapy
  • Wiskott-Aldrich Syndrome / genetics
  • Wiskott-Aldrich Syndrome / pathology
  • Wiskott-Aldrich Syndrome / therapy